| Literature DB >> 33505137 |
Sumanpreet Kaur1, Rajasri Bhattacharyya1, Dibyajyoti Banerjee1, Jaya Shukla2.
Abstract
Synergism in action of tucatinib and trastumab is reported in breast cancer management. However, its molecular basis is yet to be determined. In this context we attempted to provide an explanation at the molecular level by performing in silico experimentation and coupling its result with already available published observations. Our study will provide basis for planning further experimental study for unravelling the truth. © Association of Clinical Biochemists of India 2019.Entities:
Keywords: Breast cancer; Synergism; Trastumab; Tucatinib
Year: 2019 PMID： 33505137 PMCID： PMC7817741 DOI： 10.1007/s12291-019-00863-8
Source DB: PubMed Journal: Indian J Clin Biochem ISSN： 0970-1915